Generic Product News (January 2016)

Pharmacy TimesJanuary 2016 The Aging Population
Volume 82
Issue 1

Read about the new generic products featured in January.

Camber Pharmaceuticals

Compare to: Cozaar (Merck and Co, Inc)

Indication: Camber Pharmaceuticals has announced the launch of Losartan Potassium Tablets USP in 25-, 50-, and 100- mg tablet strengths. The drug is indicated to treat high blood pressure. The 25-mg tablet strength is available in 90-, 500-, and 1000-count bottles; the 50- and 100-mg tablet strengths are available in 90- and 1000- count bottles.

Dosage Form: Tablets: 25, 50, and 100 mg

For More Information:

Verapamil 40-mg Immediate-Release TabletsMarketed by: Heritage Pharmaceuticals, Inc

Compare to: Calan (Pfizer)

Indication: Heritage Pharmaceuticals has announced the availability of Verapamil 40-mg Immediate-Release Tablets. The product is indicated to treat angina, arrhythmias, and essential hypertension.

Dosage Form: Tablets: 40, 80, and 120 mg

For More Information:

Fluoxetine CapsulesMarketed by: Camber Pharmaceuticals

Compare to: Prozac (Eli Lilly & Co)

Indication: Camber Pharmaceuticals has announced the availability of Fluoxetine Capsules in 10-, 20-, and 40-mg tablet strengths. All 3 strengths will be available in 30- and 100-count bottles. The product is indicated to treat major depressive disorder, bulimia nervosa, obsessive-compulsive disorder, panic disorder, and premenstrual dysphoric disorder.

Dosage Form: Capsules: 10, 20, and 40 mg

For More Information:

Montelukast Sodium Oral GranulesMarketed by: Ajanta Pharma USA, Inc

Compare to: Singulair (Merck & Co, Inc)

Indication: Ajanta Pharma USA has announced the launch of Montelukast Sodium Oral Granules in a 4-mg dosage strength. The product is intended to treat chronic asthma in pediatric patients aged 6 months to 5 years.

Dosage Form: Individual sachets: 4 mg

For More Information:

Recent Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs